Vanguard Capital Management’s Oruka Therapeutics ORKA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$220M Buy
2,644,280
+283,309
+12% +$26.7M ﹤0.01% 1043
2026
Q2
$225M Buy
2,360,971
+501,340
+27% +$33.4M ﹤0.01% 1061
2026
Q1
$91.2M Hold
1,859,631
– – ﹤0.01% 1519

Other funds holding ORKA

Vanguard Capital Management's ORKA Position: Q3 2026 in Review

Vanguard Capital Management increased its Oruka Therapeutics (ORKA) stake by 12% in Q3 2026, buying an estimated $26.7M and bringing the position to 2,644,280 shares worth $220M. The position accounts for ﹤0.01% of the portfolio, ranked #1043.

Vanguard Capital Management first reported a position in ORKA in Q1 2026 and has held it in 3 quarters since. The position peaked at $225M in Q2 2026. 259 funds tracked by Wall St. Rank hold ORKA as of Q3 2026.

  • Vanguard Capital Management held 2,644,280 shares of Oruka Therapeutics worth $220M as of Q3 2026.
  • Vanguard Capital Management bought 283,309 Oruka Therapeutics shares in Q3 2026, an estimated $26.7M.
  • Oruka Therapeutics made up ﹤0.01% of Vanguard Capital Management's portfolio in Q3 2026, its #1043 holding.
  • Vanguard Capital Management first reported a position in Oruka Therapeutics in Q1 2026 and has held it in 3 quarters since.
  • Vanguard Capital Management's Oruka Therapeutics position peaked at $225M in Q2 2026.
  • 259 funds tracked by Wall St. Rank held Oruka Therapeutics as of Q3 2026.

Based on Vanguard Capital Management's 13F filing for Q3 2026, filed 13 Nov 2026.